Cancer Institute A national cancer institute
designated cancer center

Sanjiv Sam Gambhir, MD, PhD

Publication Details

  • Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor.

    Jokerst JV, Miao Z, Zavaleta C, Cheng Z, Gambhir SS. Small. 2011; 7 (5): 625-33

    The affibody functionalization of fluorescent surface-enhanced Raman scattering gold-silica nanoparticles as multimodal contrast agents for molecular imaging specific to epidermal growth factor receptor (EGFR) is reported. This nanoparticle bioconjugate reports EGFR-positive A431 tumors with a signal nearly 35-fold higher than EGFR-negative MDA-435S tumors. The low-level EGFR expression in adjacent healthy tissue is 7-fold lower than in the positive tumors. Validation via competitive inhibition reduces the signal by a factor of six, and independent measurement of EGFR via flow cytometry correlates at R(2) = 0.92.

    PubMedID: 21302357

Stanford Medicine Resources:

Footer Links: